![](gifs/hr_1.gif) |
P792 | ![InfoSheet: - Contrast Agents -
Intro, Overview,
Characteristics,
Types of,
etc.](gifs/t_ico_is.gif) ![MRI Resource Directory:
- Contrast Agents -](gifs/dir_3.gif) |
| |
|
Short name: P792, generic name: Gadomeritol, preliminary trade name: Vistaremâ„¢, central moiety: Gd
A macromolecular Gd-DOTA derivate under development as a MRI blood pool agent with rapid clearance. Phase II of the clinical trials on P792 ( Guerbet SA) will make it possible to validate the performance of this agent in the fields of angiography, myocardial perfusion and tumor characterization. | |
![spacer](gifs/nb.gif) |
|
| • Share the entry 'P792': | |
| • View the NEWS results for 'P792' (1).![Open this link in a new window. Open this link in a new window.](gifs/nw3_g.gif)
| |
| | Further Reading: | News & More:
|
|
| |